Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 9.08
-0.02 (-0.22%)
Last updated: May 7, 2026, 2:47 PM CET
Svas Biosana Market Cap
Svas Biosana has a market cap or net worth of €48.25 million as of May 7, 2026. Its market cap has increased by 27.68% in one year.
Market Cap
48.25M
Enterprise Value
93.18M
Revenue
134.95M
Ranking
n/a
PE Ratio
7.15
Stock Price
€9.08
Market Cap Chart
Since December 9, 2021, Svas Biosana's market cap has decreased from 81.14M to 48.25M, a decrease of -40.54%. That is a compound annual growth rate of -11.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 48.35M | 13.75% |
| Dec 30, 2025 | 42.51M | 10.91% |
| Dec 30, 2024 | 38.33M | -11.25% |
| Dec 29, 2023 | 43.19M | -20.87% |
| Dec 30, 2022 | 54.58M | -37.13% |
| Dec 30, 2021 | 86.80M | 6.97% |
| Dec 9, 2021 | 81.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 10.07B |
| DiaSorin | 3.28B |
| Amplifon | 2.19B |
| EL.En. | 1.06B |
| GPI S.p.A. | 453.55M |
| Talea Group | 40.74M |
| Otofarma S.P.A. | 23.03M |
| Arterra Bioscience | 20.31M |